← Open Payments lookup

HOLLY KIMBRELL: Open Payments

NPI 1093796328 · BROOKHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$900 in 43 payments from 19 companies in 2025. Trend: 2023 $917 · 2024 $1,107 · 2025 $900

Food & beverage: $900
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.5$108
AstraZeneca Pharmaceuticals LP6$103
Otsuka America Pharmaceutical, Inc.3$79
Vifor Pharma, Inc.4$78
Ardelyx, Inc.3$74
Novartis Pharmaceuticals Corporation2$57
Mallinckrodt Hospital Products Inc.3$56
SCPHARMACEUTICALS INC.2$48
Calliditas Therapeutics US Inc.2$45
Travere Therapeutics, Inc.2$42

Products named: Kerendia, FARXIGA, JYNARQUE, Veltassa, IBSRELA, ACTHAR, FUROSCIX, JARDIANCE.

Industry payments across MS — which companies pay providers there.